文献速递神经肿瘤

IDH突变胶质瘤小细胞外囊泡介导系统性免疫抑制

Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles.
PubMed 文献 · Neuro Oncol · 2022-01-01

该研究通过尺寸排阻色谱法分离人及小鼠野生型与IDH突变型胶质瘤细胞产生的小细胞外囊泡(TEX),比较其形态、数量、分子特征及体内分布。结果显示突变型IDH TEX数量更多、形态独特且免疫抑制性更强,可在荷瘤小鼠中减少瘤内效应淋巴细胞、树突状细胞和巨噬细胞,增加循环单核细胞,并加速肿瘤生长、提高死亡率。

要点

  • IDH突变胶质瘤来源TEX比野生型TEX数量更多且免疫抑制性更强。
  • 突变型IDH TEX可诱导 naive 及荷瘤小鼠系统性免疫抑制。
  • 突变型IDH TEX注入野生型荷瘤小鼠加速肿瘤生长并增加死亡率。

核心结论

  • 靶向突变型IDH胶质瘤来源的小细胞外囊泡可能成为胶质瘤的新型治疗策略。

研究设计与样本

  • 研究采用人和小鼠野生型及IDH突变型胶质瘤细胞,经尺寸排阻色谱法分离TEX,并在体外及体内模型中表征其特性与免疫功能。

主要发现

  • 突变型IDH TEX比野生型TEX数量更多、具有独特形态特征且免疫抑制性更强。
  • 突变型IDH TEX货物模拟亲本细胞,并在 naive 和荷瘤小鼠中诱导系统性免疫抑制。
  • 突变型IDH TEX注入野生型荷瘤小鼠后减少肿瘤浸润效应淋巴细胞、树突状细胞和巨噬细胞,增加循环单核细胞。
  • 突变型IDH TEX注入脑肿瘤同系小鼠后较野生型TEX加速肿瘤生长并增加死亡率。

临床怎么用

  • 该研究提示突变型IDH胶质瘤TEX是潜在的免疫治疗靶点,但尚未提供临床可用的阈值或干预方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gliomas are the most common primary brain tumors and are universally fatal. Mutations in the isocitrate dehydrogenase genes (IDH1 and IDH2) define a distinct glioma subtype associated with an immunosuppressive tumor microenvironment. Mechanisms underlying systemic immunosuppression in IDH mutant (mutIDH) gliomas are largely unknown. Here, we define genotype-specific local and systemic tumor immunomodulatory functions of tumor-derived glioma small extracellular vesicles (TEX). METHODS: TEX produced by human and murine wildtype and mutant IDH glioma cells (wtIDH and mutIDH, respectively) were isolated by size exclusion chromatography (SEC). TEX morphology, size, quantity, molecular profiles and biodistribution were characterized. TEX were injected into naive and tumor-bearing mice, and the local and systemic immune microenvironment composition was characterized. RESULTS: Using in vitro and in vivo glioma models, we show that mutIDH TEX are more numerous, possess distinct morphological features and are more immunosuppressive than wtIDH TEX. mutIDH TEX cargo mimics their parental cells, and induces systemic immune suppression in naive and tumor-bearing mice. TEX derived from mutIDH gliomas and injected into wtIDH tumor-bearing mice reduce tumor-infiltrating effector lymphocytes, dendritic cells and macrophages, and increase circulating monocytes. Astonishingly, mutIDH TEX injected into brain tumor-bearing syngeneic mice accelerate tumor growth and increase mortality compared with wtIDH TEX. CONCLUSIONS: Targeting of mutIDH TEX represents a novel therapeutic approach in gliomas.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ludwig N, Rao A, Sandlesh P, et al. Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles. Neuro Oncol. 2022. PMID: 34254643. doi:10.1093/neuonc/noab153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。